Generate Biomedicines, Inc. (GENB)
17.14
+0.02
(+0.12%)
USD |
NASDAQ |
Sep 18, 16:00
17.17
+0.03
(+0.18%)
After-Hours: 20:00
Generate Biomedicines Cash from Investing (Quarterly) : 33.31M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.31M |
| March 31, 2026 | -252.43M |
| Date | Value |
|---|---|
| June 30, 2025 | -15.07M |
| March 31, 2025 | 76.28M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Twist Bioscience Corp. | -10.20M |
| Intellia Therapeutics, Inc. | -141.57M |
| Prime Medicine, Inc. | 24.03M |
| Moderna, Inc. | 329.00M |
| Beam Therapeutics, Inc. | -9.875M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -57.94M |
| Cash from Financing (Quarterly) | -0.579M |
| Free Cash Flow | -245.88M |
| Free Cash Flow Per Share (Quarterly) | -0.459 |
| Free Cash Flow to Equity (Quarterly) | -55.94M |
| Free Cash Flow to Firm (Quarterly) | -58.72M |
| Free Cash Flow Yield | -17.79% |